2026 Summer Internship Program: Vaccine Business Unit Product Operations Assay Development Intern jobs in United States
cer-icon
Apply on Employer Site
company-logo

Takeda · 2 days ago

2026 Summer Internship Program: Vaccine Business Unit Product Operations Assay Development Intern

Takeda is a leading global biotechnology company focused on developing innovative medicines. The Vaccine Business Unit Product Operations Assay Development Intern will contribute to vaccine manufacturing by providing analytical methodologies and supporting analytical testing in GMP quality control laboratories.

BiotechnologyHealth CareManufacturingMedicalPharmaceutical
badNo H1Bnote

Responsibilities

Plan and execute wet-lab experiments
Analyze data
Interpret and present results and conclusions to the larger development team
Use findings to inform further development strategy and/or finalize analytical procedure operating parameters

Qualification

Wet-lab experimentsData analysisAnalytical methodologiesMicropipette usageTeam collaboration

Required

Must be pursuing a Bachelors Degree in biology, chemistry, biochemistry, or another relevant field
Basic experience in a research laboratory, including usage of micropipettes
Willingness to wear appropriate PPE to meet safety requirements while working in a BSL-2 environment
Demonstrated ability to work effectively as a collaborative team member
Must be authorized to work in the U.S. on a permanent basis without requiring sponsorship
Must be currently enrolled in a degree program graduating December 2026 or later
Able to work full time 40 hours a week during internship dates

Benefits

Paid sick time
Civic Duty paid time off
Participation at company volunteer events
Participation at company sponsored special events
Access to on-site fitness center (where available)
Commuter Benefit To offset your work-commute expenses, Takeda provides U.S. employees with a fixed monthly subsidy to be used for either public transportation (transit) or parking.

Company

Takeda

twittertwittertwitter
company-logo
Takeda is a biopharmaceutical company that researches and develops pharmaceutical drugs.

Funding

Current Stage
Public Company
Total Funding
$2.46B
2025-06-27Post Ipo Debt· $2.4B
2016-09-01Grant· $19.8M
2016-05-08Grant· $38M

Leadership Team

leader-logo
Christophe Weber
President and CEO
linkedin
leader-logo
Schuyler Fairfield
Senior Vice President, Global Head of Supply Chain
linkedin
Company data provided by crunchbase